- Home
- OFG vs TARS Comparison
OFG vs TARS Comparison
Compare OFG & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFG
- TARS
- Stock Information
- Founded
- OFG 1964
- TARS 2016
- Country
- OFG United States
- TARS United States
- Employees
- OFG N/A
- TARS N/A
- Industry
- OFG Major Banks
- TARS Medicinal Chemicals and Botanical Products
- Sector
- OFG Finance
- TARS Health Care
- Exchange
- OFG Nasdaq
- TARS Nasdaq
- Market Cap
- OFG 2.0B
- TARS 1.7B
- IPO Year
- OFG N/A
- TARS 2020
- Fundamental
- Price
- OFG $42.65
- TARS $65.17
- Analyst Decision
- OFG Buy
- TARS Strong Buy
- Analyst Count
- OFG 3
- TARS 7
- Target Price
- OFG $46.67
- TARS $67.14
- AVG Volume (30 Days)
- OFG 238.5K
- TARS 748.0K
- Earning Date
- OFG 10-22-2025
- TARS 11-12-2025
- Dividend Yield
- OFG 2.81%
- TARS N/A
- EPS Growth
- OFG 4.40
- TARS N/A
- EPS
- OFG 4.25
- TARS N/A
- Revenue
- OFG $619,470,000.00
- TARS $295,521,000.00
- Revenue This Year
- OFG N/A
- TARS $137.28
- Revenue Next Year
- OFG $1.89
- TARS $42.84
- P/E Ratio
- OFG $10.04
- TARS N/A
- Revenue Growth
- OFG N/A
- TARS 254.45
- 52 Week Low
- OFG $33.15
- TARS $31.99
- 52 Week High
- OFG $47.66
- TARS $65.97
- Technical
- Relative Strength Index (RSI)
- OFG 38.40
- TARS 74.43
- Support Level
- OFG $42.18
- TARS $56.25
- Resistance Level
- OFG $44.87
- TARS $59.78
- Average True Range (ATR)
- OFG 0.81
- TARS 2.57
- MACD
- OFG -0.23
- TARS 0.71
- Stochastic Oscillator
- OFG 15.67
- TARS 95.35
About OFG OFG Bancorp
OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.